INVESTOR relations
Firm
Analyst
Roth Capital Partners
Andrew Vaino
Cowen and Company
Ian Sanderson
Versant Partners
Doug Loe
GMP Securities
Cosme Ordoñez
Paradigm Capital
Claude Camiré
RBC Dominion Securities
Douglas Miehm
Cormark Securities
David Dean
Laurentian Bank Securities
Catherine Bouchard
Canaccord Adams
Neil Maruoka
Bloom Burton & Co.
Philippa Flint
Please note that any opinions, estimates or forecasts regarding Transition's performance made by the analysts listed above are theirs alone and do not represent opinions, forecasts or predictions of Transition Therapeutics Inc. or its management. Transition Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.